当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 资产负债表

金陵药业

(000919)

  

流通市值:40.97亿  总市值:43.16亿
流通股本:5.90亿   总股本:6.22亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金1,328,637,013.441,323,186,708.621,770,945,293.911,254,484,540.88
  结算备付金000-
  拆出资金000-
  交易性金融资产1,232,408,409.791,042,055,857.89706,046,500.54852,029,018.16
  衍生金融资产000-
  应收票据及应收账款708,923,504.49767,314,781.13686,725,108.33747,662,546.04
  其中:应收票据135,642,318.23196,772,224.74247,800,384.48207,040,765.34
        应收账款573,281,186.26570,542,556.39438,924,723.85540,621,780.7
  应收款项融资000-
  预付款项5,804,984.3111,516,742.834,490,272.6219,861,369.15
  应收保费000-
  应收分保账款000-
  应收分保合同准备金000-
  其他应收款合计5,811,217.547,910,505.917,231,221.129,031,224.78
  其中:应收利息000-
        应收股利000-
  买入返售金融资产000-
  存货242,228,006.06250,837,970.04271,624,277.17248,069,135.45
  合同资产000-
  一年内到期的非流动资产103,503,835.6236,024,657.53165,219,589.0410,000,000
  其他流动资产11,612,354.0812,754,169.715,811,480.628,702,843.33
  流动资产合计3,638,929,325.313,651,601,393.663,618,093,743.353,149,840,677.79
非流动资产:
  发放委托贷款及垫款000-
  债权投资000-
  其他债权投资000-
  长期应收款000-
  长期股权投资60,076,341.4758,637,694.1860,309,482.72253,729,611.24
  其他权益工具投资406,542.26406,542.26586,084.341,013,253.08
  其他非流动金融资产000-
  投资性房地产8,030,393.168,281,688.018,532,982.867,681,145.21
  固定资产1,382,899,136.971,376,306,537.721,396,190,053.421,279,445,063.91
  在建工程84,609,989.3796,510,751.2971,782,383.528,010,980.92
  生产性生物资产1,021,353.351,068,469.021,119,616.421,172,255.12
  油气资产000-
  使用权资产30,685,234.5431,611,339.5532,213,882.753,915,143.75
  无形资产322,126,402.23321,941,347.67325,673,286.79255,797,658.14
  开发支出0003,498,113.21
  商誉62,418,871.6362,418,871.6362,418,871.6327,331,541.79
  长期待摊费用77,081,776.0287,462,249.3583,339,882.9411,401,344.56
  递延所得税资产12,459,325.0515,834,764.3812,493,908.75-
  其他非流动资产373,802,335.88346,287,001.27416,100,846.12333,012,502.87
  非流动资产合计2,415,617,701.932,406,767,256.332,470,761,282.242,206,008,613.8
  资产总计6,054,547,027.246,058,368,649.996,088,855,025.595,355,849,291.59
流动负债:
  短期借款000-
  向中央银行借款000-
  吸收存款及同业存放000-
  拆入资金000-
  交易性金融负债000-
  衍生金融负债000-
  应付票据及应付账款541,972,732.39597,771,165.43595,307,084.31511,607,662.63
  其中:应付票据55,493,900.5647,424,300.2137,889,967.1447,159,118.42
        应付账款486,478,831.83550,346,865.22557,417,117.17464,448,544.21
  预收款项2,432,793.41535,753.081,260,079.351,259,270.5
  合同负债26,950,479.3721,915,926.7735,600,964.5924,424,601.82
  卖出回购金融资产款000-
  应付手续费及佣金000-
  应付职工薪酬78,543,025.2757,137,192.39117,181,894.1588,115,710.83
  应交税费55,325,136.9556,456,415.4945,274,782.938,213,193.99
  其他应付款合计306,395,756.48228,766,199.47227,444,183.35228,792,461.91
  其中:应付利息000-
        应付股利70,210,862.800-
  应付分保账款000-
  保险合同准备金000-
  代理买卖证券款000-
  代理承销证券款000-
  一年内到期的非流动负债2,769,179.472,765,780.114,233,069.22,306,469.24
  其他流动负债822,443742,733.93724,381.911,891,613.55
  流动负债合计1,015,211,546.34966,091,166.671,027,026,439.76896,610,984.47
非流动负债:
  长期借款150,088,125150,123,750150,123,750-
  应付债券000-
  优先股000-
  永续债000-
  租赁负债37,067,200.7336,697,789.9134,851,069.721,515,966.56
  长期应付款000-
  长期应付职工薪酬000-
  预计负债000-
  递延收益841,692.52961,554.541,001,416.56387,807.27
  递延所得税负债28,326,119.930,825,10027,275,725.919,831,751.91
  其他非流动负债000-
  非流动负债合计216,323,138.15218,608,194.45213,251,962.1821,735,525.74
  负债合计1,231,534,684.491,184,699,361.121,240,278,401.94918,346,510.21
所有者权益(或股东权益):
  实收资本(或股本)623,708,628623,708,628623,708,628629,060,528
  其他权益工具000-
  优先股000-
  永续债000-
  资本公积1,093,258,661.591,097,873,201.131,097,873,201.131,105,691,414.84
  减:库存股6,768,8196,768,8196,768,81926,994,240
  其他综合收益2,512,226.612,512,226.612,512,226.612,551,457.02
  专项储备392,426.22523,709.21577,165.24916,877.51
  盈余公积415,026,062.19415,026,062.19415,026,062.19408,647,578.17
  一般风险准备000-
  未分配利润1,644,303,452.91,681,144,362.391,658,162,373.251,674,591,243.63
  归属于母公司股东权益合计3,772,432,638.513,814,019,370.533,791,090,837.423,794,464,859.17
  少数股东权益1,050,579,704.241,059,649,918.341,057,485,786.23643,037,922.21
  股东权益合计4,823,012,342.754,873,669,288.874,848,576,623.654,437,502,781.38
  负债和股东权益合计6,054,547,027.246,058,368,649.996,088,855,025.595,355,849,291.59
公告日期2025-08-282025-04-282025-03-292024-10-29
审计意见(境内)标准无保留意见
TOP↑